Hypothesis testing and estimation in a group sequential phase II/III clinical trial

Add to your list(s) Download to your calendar using vCal

• Nigel Stallard, University of Warwick
• Tuesday 10 March 2009, 14:30-15:30
• Large Seminar Room, 1st Floor, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge.

If you have a question about this talk, please contact Michael Sweeting.

Most statistical methodology for phase III clinical trials focuses on the comparison of a single experimental treatment with a control treatment, with selection of the treatment made in a phase II trial. Recently, however, there has been increasing interest in methods for phase II/III trials that combine the treatment selection element of a phase II clinical trial with the definitive analysis associated with phase III clinical trials.

This talk will describe a method for combining phases II and III in a single phase II/III clinical trial that proceeds in a number of stages. The first stage is rather like the usual phase II trial, with patients randomised between a control treatment and a number of experimental treatments. At the end of this stage, the best experimental treatment is selected. If this is clearly superior or clearly inferior to the control treatment, the trial might be stopped at this point either for efficacy or for futility respectively. If the trial is not stopped, it continues to the second stage, which is more like the usual phase III trial, with recruitment to the control arm and the selected experimental treatment arm alone. The second stage may itself include interim analyses comparing the two treatments. An extension of the group-sequential approach will be used to ensure that the overall type I error rate is controlled at the specified level.

The talk will conclude with a discussion of the problem of estimation of treatment effects after a trial in which treatment selection has taken place.

This talk is part of the MRC Biostatistics Unit Seminars series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• BHRU Annual Lecture 2015
• BHRU Annual Lecture 2016
• Biology
• Cambridge Centre for Data-Driven Discovery (C2D3)
• Cambridge Immunology
• Cambridge talks
• Cardiovascular Epidemiology Unit Special Seminars
• Chris Davis' list
• Department of Public Health and Primary Care
• Graduate-Seminars
• Interested Talks
• Large Seminar Room, 1st Floor, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge
• Life Sciences
• Life Sciences
• ME Seminar
• MRC Biostatistics Unit Seminars
• Primary Care
• PublicHealth@Cambridge
• Trust & Technology Initiative - interesting events
• bld31
• my_list
• ndk22's list
• ob366-ai4er
• other talks
• primary care
• rp587

Note that ex-directory lists are not shown.